MedTrace Logo

Breast Cancer Chemotherapy Risk Prediction Mathematical Model

NCT02547545 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 795

Last updated 2016-08-10

No results posted yet for this study

Summary

This is a cohort study. This study is to develop a predictive model of the side effects after chemotherapy, exploreing the potential risk factors of the side effects such as myelosuppression and chemotherapy realted vomit after the chemotherapy, so that it could help to alleviate patients' fear and anxiety about the side effects and the toxicity of chemotherapy. The potential risk factors were measured at baseline.

Conditions

  • Breast Neoplasms

Sponsors & Collaborators

  • Shaanxi Hospital of Traditional Chinese Medicine

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    lead OTHER

Principal Investigators

  • Yi Liu, MD,PHD · +86 18991232576

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-03-31
Completion
2017-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02547545 on ClinicalTrials.gov